Connor Clark & Lunn Investment Management Ltd. Buys New Position in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS)
Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 13,478 shares of the company’s stock, valued at approximately $430,000. A number of other hedge funds and other institutional investors also recently bought and […]
Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 13,478 shares of the company’s stock, valued at approximately $430,000. A number of other hedge funds and other institutional investors also recently bought and […]
